Paradoxical and atypical responses to pasireotide in aggressive ACTH-secreting pituitary tumors.

Published in: Pituitary (2017)

We describe as yet unreported atypical responses to pasireotide treatment in patients with aggressive ACTH-secreting tumors. Increased vigilance is recommended during pasireotide treatment of such patients.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
replacement therapy